Veterinary Medicines

Api-Bioxal 632.7 mg/g bee-hive powder

Authorised
  • Oxalic acid dihydrate
Download as PDF

Product identification

Medicine name:
Api-Bioxal 632.7 mg/g bee-hive powder
API-Bioxal 886 mg/g polvere per alveare
Active substance:
  • Oxalic acid dihydrate
Target species:
  • Honey bee
Route of administration:
  • In-hive use

Product details

Active substance and strength:
  • Oxalic acid dihydrate
    886.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Bee-hive powder
Withdrawal period by route of administration:
  • In-hive use
    • Honey bee
      • Honey
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AG03
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Package description:
  • Multilayer polyester-Aluminium-Polyethylene laminated bags, heat sealed, containing 350 g of powder.
  • Multilayer polyester-Aluminium-Polyethylene laminated bags, heat sealed, containing 175 g of powder.
  • Multilayer polyester-Aluminium-Polyethylene laminated bags, heat sealed, containing 35 g of powder.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Chemicals Laif S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chemifarma S.p.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 104384
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0132/001
Concerned member states:
  • Austria
  • Bulgaria
  • Croatia
  • France
  • Ireland
  • Norway
  • Portugal
  • Romania
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 11/11/2024
Download
Italian (PDF)
Published on: 2/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."